Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
    • Corporate governance
    • Contact

    Investors

    Investors

    Corporate Profile

    Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.

    AST Shareholder Services:
    www.astfinancial.com/contact-us
    (800) 937-5449

    Stock Information

    Change
    Volume
    52 Week High
    52 Week Low
    Mar 30, 2023 8:15 PM EDT

    Data Provided by Refinitiv. Minimum 15 minutes delayed.

    Press Releases

    • Daré Bioscience Reports Full Year 2022 Financial Results and Provides a Company Update

      03-30-2023

    • Daré Bioscience to Host Full-year 2022 Financial Results and Company Update Conference Call and Webcast on March 30, 2023

      03-23-2023

    • Daré Bioscience to Present at the 35th Annual Roth Conference

      03-01-2023

    View all press releases »

    Events & Presentations

    • Daré Bioscience, Inc. Q4 2022 Conference Call

      03-30-2023 at 4:30 PM EDT

      Listen to webcast
    View all events & presentations »
    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top